Market Closed -
Australian S.E.
02:10:44 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
0.42
AUD
|
-6.67%
|
|
+18.31%
|
+21.74%
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
84.71
|
75.58
|
411.5
|
247.7
|
374
|
499.3
|
-
|
-
|
Enterprise Value (EV)
1 |
75.79
|
58.31
|
350.9
|
169.2
|
251.4
|
420.6
|
448.6
|
454
|
P/E ratio
|
-4.39
x
|
-4.61
x
|
-10.9
x
|
-7.65
x
|
-7.05
x
|
-10.8
x
|
-12.2
x
|
15.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
11.3
x
|
4.58
x
|
-
|
36.7
x
|
71.9
x
|
156
x
|
25.2
x
|
3.03
x
|
EV / Revenue
|
10.1
x
|
3.53
x
|
-
|
25
x
|
48.3
x
|
132
x
|
22.7
x
|
2.75
x
|
EV / EBITDA
|
-4.14
x
|
-
|
-20
x
|
-5.63
x
|
-6.65
x
|
-8.96
x
|
-11.4
x
|
7.11
x
|
EV / FCF
|
-4.94
x
|
-5.37
x
|
-19.9
x
|
-5.59
x
|
-7.09
x
|
-8.95
x
|
-7.12
x
|
4.66
x
|
FCF Yield
|
-20.2%
|
-18.6%
|
-5.03%
|
-17.9%
|
-14.1%
|
-11.2%
|
-14%
|
21.5%
|
Price to Book
|
-
|
-
|
-
|
2.62
x
|
2.74
x
|
5
x
|
8.87
x
|
4.08
x
|
Nbr of stocks (in thousands)
|
338,860
|
487,631
|
748,153
|
854,123
|
1,187,306
|
1,188,835
|
-
|
-
|
Reference price
2 |
0.2500
|
0.1550
|
0.5500
|
0.2900
|
0.3150
|
0.4200
|
0.4200
|
0.4200
|
Announcement Date
|
8/20/19
|
8/25/20
|
8/30/21
|
8/31/22
|
8/29/23
|
-
|
-
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
7.489
|
16.5
|
-
|
6.758
|
5.2
|
3.191
|
19.78
|
164.8
|
EBITDA
1 |
-18.32
|
-
|
-17.59
|
-30.05
|
-37.81
|
-46.96
|
-39.27
|
63.86
|
EBIT
1 |
-20.2
|
-12.31
|
-19.66
|
-32.12
|
-39.88
|
-47.38
|
-41.46
|
40.51
|
Operating Margin
|
-269.66%
|
-74.61%
|
-
|
-475.26%
|
-766.83%
|
-1,484.83%
|
-209.6%
|
24.58%
|
Earnings before Tax (EBT)
1 |
-18.34
|
-13.47
|
-29.9
|
-32.21
|
-39.9
|
-45.9
|
-40.88
|
58.78
|
Net income
1 |
-18.34
|
-13.47
|
-29.9
|
-32.21
|
-39.9
|
-45.23
|
-40.86
|
22.8
|
Net margin
|
-244.93%
|
-81.63%
|
-
|
-476.63%
|
-767.22%
|
-1,417.47%
|
-206.6%
|
13.83%
|
EPS
2 |
-0.0570
|
-0.0336
|
-0.0503
|
-0.0379
|
-0.0447
|
-0.0387
|
-0.0343
|
0.0277
|
Free Cash Flow
1 |
-15.33
|
-10.86
|
-17.66
|
-30.25
|
-35.44
|
-47
|
-63
|
97.5
|
FCF margin
|
-204.66%
|
-65.81%
|
-
|
-447.65%
|
-681.49%
|
-1,472.79%
|
-318.52%
|
59.16%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
152.67%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
427.59%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/20/19
|
8/25/20
|
8/30/21
|
8/31/22
|
8/29/23
|
-
|
-
|
-
|
Fiscal Period: June |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
2.08
|
3.906
|
-
|
2.617
|
4.11
|
0.6667
|
EBITDA
1 |
-
|
-
|
-9.341
|
-8.245
|
-14.95
|
-15.68
|
-
|
-
|
-
|
-26
|
EBIT
1 |
-5.373
|
-6.938
|
-10.39
|
-9.262
|
-16.84
|
-15.86
|
-20.61
|
-19.27
|
-21.22
|
-26.2
|
Operating Margin
|
-
|
-
|
-
|
-
|
-809.62%
|
-405.89%
|
-
|
-736.14%
|
-516.19%
|
-3,929.98%
|
Earnings before Tax (EBT)
1 |
-5.95
|
-7.518
|
-19.84
|
-10.06
|
-16.27
|
-15.94
|
-20.62
|
-19.27
|
-21.23
|
-25.3
|
Net income
1 |
-5.95
|
-7.518
|
-19.84
|
-10.06
|
-16.27
|
-15.94
|
-20.62
|
-19.27
|
-21.23
|
-24.95
|
Net margin
|
-
|
-
|
-
|
-
|
-782.21%
|
-408.07%
|
-
|
-736.35%
|
-516.45%
|
-3,742.48%
|
EPS
2 |
-
|
-
|
-0.0383
|
-0.0120
|
-0.0200
|
-0.0185
|
-0.0236
|
-
|
-0.0179
|
-0.0200
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/20/20
|
8/25/20
|
2/23/21
|
8/30/21
|
2/24/23
|
8/31/22
|
2/24/23
|
8/29/23
|
2/27/24
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
8.93
|
17.3
|
60.6
|
78.5
|
123
|
78.7
|
50.7
|
45.4
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-15.3
|
-10.9
|
-17.7
|
-30.3
|
-35.4
|
-47
|
-63
|
97.5
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-56.1%
|
-38.5%
|
-34.6%
|
-48.1%
|
-104%
|
-34.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-46.5%
|
-35%
|
-32%
|
-44.2%
|
-127%
|
-137%
|
Assets
1 |
-
|
-
|
64.32
|
92.1
|
124.8
|
102.3
|
32.23
|
-16.67
|
Book Value Per Share
2 |
-
|
-
|
-
|
0.1100
|
0.1100
|
0.0800
|
0.0500
|
0.1000
|
Cash Flow per Share
2 |
-
|
-
|
-0.0300
|
-0.0400
|
-0.0400
|
-0.0200
|
-0.1000
|
-
|
Capex
1 |
0.04
|
0.02
|
0.02
|
0.02
|
0.08
|
0.03
|
0.06
|
0.08
|
Capex / Sales
|
0.55%
|
0.12%
|
-
|
0.34%
|
1.59%
|
1.05%
|
0.3%
|
0.05%
|
Announcement Date
|
8/20/19
|
8/25/20
|
8/30/21
|
8/31/22
|
8/29/23
|
-
|
-
|
-
|
Last Close Price
0.42
AUD Average target price
0.9725
AUD Spread / Average Target +131.55% Consensus |
1st Jan change
|
Capi.
|
---|
| +21.74% | 326M | | +1.51% | 42.75B | | +49.22% | 41.61B | | +8.57% | 41.34B | | -12.36% | 26.59B | | +8.92% | 25.49B | | -25.13% | 18.12B | | +29.17% | 12.24B | | -3.12% | 11.76B | | +6.35% | 11B |
Other Biotechnology & Medical Research
|